The ALS Therapy Development Institute (ALS TDI) and its scientists actively discover and develop treatments for ALS. It is the world’s first and largest nonprofit biotech focused 100% on ALS research. Led by people with ALS and drug development experts, ALS TDI understands the urgent need to slow and stop this disease.
Based in Cambridge, MA, ALS TDI has over 30 full-time, industry trained, drug discovery experts on staff. This interdisciplinary team of scientists works 24/7 in ALS TDI’s state-of-the-art laboratory and partners with pharmaceutical and biotech companies around the world.